Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay ; volume:12 ; number:1 ; day:28 ; month:9 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (28.9.2022), 1-13, 12.2022
- Urheber
-
Nepomuceno, Thales C.
Santos, Ana P. P. dos
Fernandes, Vanessa C.
Elias, Anna B. R.
Gomes, Thiago T.
Suarez-Kurtz, Guilherme
Iversen, Edwin S.
Couch, Fergus J.
Monteiro, Alvaro N. A.
Carvalho, Marcelo A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-20500-4
- URN
-
urn:nbn:de:101:1-2022121621200816190171
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nepomuceno, Thales C.
- Santos, Ana P. P. dos
- Fernandes, Vanessa C.
- Elias, Anna B. R.
- Gomes, Thiago T.
- Suarez-Kurtz, Guilherme
- Iversen, Edwin S.
- Couch, Fergus J.
- Monteiro, Alvaro N. A.
- Carvalho, Marcelo A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Ten modifiers of BRCA1 penetrance validated in a Norwegian series
Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
"Pernicious nonsense"
Nonsense verse
Nonsense novels
Advocate-BREAST: advocates and patients’ advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Ten modifiers of BRCA1 penetrance validated in a Norwegian series
Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
"Pernicious nonsense"
Nonsense verse
Nonsense novels
Advocate-BREAST: advocates and patients’ advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Ten modifiers of BRCA1 penetrance validated in a Norwegian series
Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
"Pernicious nonsense"
Nonsense verse
Nonsense novels